| Published Application/Species/Sample/Dilution | Reference |
|---|
- flow cytometry; human; loading ...; fig 1e
| Ruiz Gutierrez M, Bölükbaşı Ö, Alexe G, Kotini A, Ballotti K, Joyce C, et al. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight. 2019;5: pubmed publisher |
- immunocytochemistry; human; 1:125; loading ...; fig s10a
| Chen X, Janssen J, Liu J, Maggio I, t Jong A, Mikkers H, et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat Commun. 2017;8:657 pubmed publisher |
- immunocytochemistry; human; 1:200; loading ...; tbl s4
| Hansen S, Stummann T, Borland H, Hasholt L, Tumer Z, Nielsen J, et al. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3. Stem Cell Res. 2016;17:306-317 pubmed publisher |
- immunocytochemistry; human; 1:200; loading ...; tbl 2
| Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11. Stem Cell Res. 2016;16:589-92 pubmed publisher |
- immunocytochemistry; human; 1:200; fig 1d
| Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11. Stem Cell Res. 2016;16:553-6 pubmed publisher |
| Klaihmon P, Luanpitpong S, Kang X, Issaragrisil S. Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells. Cancer Cell Int. 2023;23:297 pubmed publisher |
| Frank E, Cailleret M, Nelep C, Fragner P, Polentes J, Herardot E, et al. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones. Stem Cell Res Ther. 2023;14:110 pubmed publisher |
| Liu Y, Yang Y, Suo Y, Li C, Chen M, Zheng S, et al. Inducible caspase-9 suicide gene under control of endogenous oct4 to safeguard mouse and human pluripotent stem cell therapy. Mol Ther Methods Clin Dev. 2022;24:332-341 pubmed publisher |
| de Lamotte J, Polentes J, Roussange F, Lesueur L, Feurgard P, Perrier A, et al. Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins. Stem Cell Res Ther. 2021;12:599 pubmed publisher |
| Kim S, Wong Y, Gao F, Krainc D. Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson's disease. Nat Commun. 2021;12:1807 pubmed publisher |
| Themeli M, Chhatta A, Boersma H, Prins H, Cordes M, de Wilt E, et al. iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests. Stem Cell Reports. 2020;14:300-311 pubmed publisher |
| Sanchez Duffhues G, Mikkers H, De Jong D, Szuhai K, de Vries T, Freund C, et al. Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts. Stem Cell Res. 2019;41:101639 pubmed publisher |
| Frederiksen H, Holst B, Mau Holzmann U, Freude K, Schmid B. Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene. Stem Cell Res. 2019;35:101403 pubmed publisher |
| Schmid B, Prehn K, Nimsanor N, Garcia B, Poulsen U, Jørring I, et al. Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line. Stem Cell Res. 2019;34:101349 pubmed publisher |
| Melamed Z, López Erauskin J, Baughn M, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22:180-190 pubmed publisher |
| Frederiksen H, Holst B, Ramakrishna S, Muddashetty R, Schmid B, Freude K. Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene. Stem Cell Res. 2019;34:101368 pubmed publisher |
| Claassen J, Zhang D, Chen S, Moon S, Lamey T, Thompson J, et al. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy. Stem Cell Res. 2019;34:101352 pubmed publisher |
| McLenachan S, Zhang D, Zhang X, Chen S, Lamey T, Thompson J, et al. Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier. Stem Cell Res. 2019;34:101357 pubmed publisher |
| Hey C, Saltõkowa K, Larsen L, Tumer Z, Brøndum Nielsen K, Grønskov K, et al. Generation of induced pluripotent stem cells, KCi002-A derived from a patient with Bardet-Biedl syndrome homozygous for the BBS10 variant c.271insT. Stem Cell Res. 2018;33:46-50 pubmed publisher |
| Hey C, Saltõkowa K, Larsen L, Tumer Z, Brøndum Nielsen K, Grønskov K, et al. Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C. Stem Cell Res. 2018;31:235-239 pubmed publisher |
| Slamecka J, McClellan S, Wilk A, Laurini J, Manci E, Hoerstrup S, et al. Induced pluripotent stem cells derived from human amnion in chemically defined conditions. Cell Cycle. 2018;17:330-347 pubmed publisher |
| Huggins I, Bos T, Gaylord O, Jessen C, Lonquich B, Puranen A, et al. The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells. Nat Commun. 2017;8:1034 pubmed publisher |
| Chao M, Gentles A, Chatterjee S, Lan F, Reinisch A, Corces M, et al. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. Cell Stem Cell. 2017;20:329-344.e7 pubmed publisher |
| Slamecka J, Salimova L, McClellan S, van Kelle M, Kehl D, Laurini J, et al. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions. Cell Cycle. 2016;15:234-49 pubmed publisher |
| Devine M, Ryten M, Vodicka P, Thomson A, Burdon T, Houlden H, et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun. 2011;2:440 pubmed publisher |
| Kamata M, Liang M, Liu S, Nagaoka Y, Chen I. Live cell monitoring of hiPSC generation and differentiation using differential expression of endogenous microRNAs. PLoS ONE. 2010;5:e11834 pubmed publisher |
